Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
Bioorg Med Chem Lett
; 23(11): 3416-20, 2013 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-23591110
ABSTRACT
A series of structurally novel aryl ureas was derived from optimization of the HTS lead as selective histamine H3 receptor (H3R) antagonists. The SAR was explored and the data obtained set up the starting point and foundation for further optimization. The most potent tool compounds, as exemplified by compounds 2l, 5b, 5d, and 5e, displayed antagonism potencies in the subnanomolar range in in vitro human-H3R FLIPR assays and rhesus monkey H3R binding assays.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urea
/
Receptors, Histamine H3
/
Histamine H3 Antagonists
/
Amides
Limits:
Animals
/
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2013
Document type:
Article
Affiliation country: